EMP and cancer stemness may act cooperatively to enhance anoikis resistance, as Frisch and colleagues showed that in breast cancer, the cancer stem cell marker CD44S, which is up-regulated in response to an EMT, can enhance cell survival under detached conditions (Cieply et al., 2015). The gene discussed is MAEA; the disease is cancer.